[Therapeutical approach to involuntary movements (author's transl)].
Thirty-three patients presenting an extra-pyramidal pathology with important involuntary movements have been treated with tiapride. The main beneficial results have been obtained in Huntington's chorea and in certain types of myoclony. The association with L-dopa, must be discussed. Only some L-dopa induced dyskinesias are improved; moreover tiaprid may antagonize L-dopa. The essential familial tremor is never improved.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001549:Benzamides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy; D004421:Dystonia / Q000188:drug therapy; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D007980:Levodopa / Q000009:adverse effects; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy*; D009207:Myoclonus / Q000188:drug therapy; D014103:Torticollis / Q000188:drug therapy
D001549:Benzamides; D007980:Levodopa
Abord thérapeutique des mouvements anormaux.